ClearPoint Neuro (CLPT) News Today $12.08 -0.71 (-5.51%) As of 03:47 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CLPT Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period 41,900 Shares in ClearPoint Neuro, Inc. (NASDAQ:CLPT) Purchased by OMERS ADMINISTRATION CorpOMERS ADMINISTRATION Corp purchased a new stake in shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 41,900 shares of the company's stock, valued at approximatelMay 21 at 4:54 AM | marketbeat.comContrasting ClearPoint Neuro (NASDAQ:CLPT) and Neuronetics (NASDAQ:STIM)May 21 at 2:15 AM | americanbankingnews.comD. E. Shaw & Co. Inc. Increases Stake in ClearPoint Neuro, Inc. (NASDAQ:CLPT)D. E. Shaw & Co. Inc. increased its stake in ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) by 27.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 288,409 shares of the compMay 20 at 4:20 AM | marketbeat.comClearPoint Neuro Updates Director Compensation PlanMay 19 at 5:25 PM | tipranks.comClearPoint Neuro First Quarter 2025 Earnings: Revenues Beat Expectations, EPS LagsMay 17, 2025 | uk.finance.yahoo.comQ2 Earnings Estimate for ClearPoint Neuro Issued By B. RileyMay 17, 2025 | americanbankingnews.comJane Street Group LLC Boosts Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT)Jane Street Group LLC boosted its stake in shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) by 119.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 222,307 shares of the company's stockMay 15, 2025 | marketbeat.comClearPoint Neuro, Inc. (CLPT) Q1 2025 Earnings Call TranscriptMay 13, 2025 | seekingalpha.comClearPoint Neuro Inc (CLPT) Q1 2025 Earnings Report Preview: What to Look ForMay 13, 2025 | finance.yahoo.comClearPoint Neuro, Inc.: ClearPoint Neuro Reports First Quarter 2025 ResultsMay 13, 2025 | finanznachrichten.deClearPoint Neuro, Inc.: ClearPoint Neuro Announces Investment of up to $110 Million by Oberland Capital with $33.5 Million Funded at ClosingMay 12, 2025 | finanznachrichten.deClearPoint Neuro, Inc. Q1 2025 Earnings PreviewMay 12, 2025 | msn.comSchonfeld Strategic Advisors LLC Buys Shares of 106,172 ClearPoint Neuro, Inc. (NASDAQ:CLPT)Schonfeld Strategic Advisors LLC purchased a new position in ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 106,172 shares of the compMay 9, 2025 | marketbeat.comMarshall Wace LLP Sells 263,779 Shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT)Marshall Wace LLP lessened its holdings in shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) by 95.4% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 12,853 shares of the company's stock after selling 263,779May 8, 2025 | marketbeat.comClearPoint Neuro, Inc. (NASDAQ:CLPT) Shares Bought by Barclays PLCBarclays PLC increased its stake in ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) by 1,070.9% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 66,436 shares of the company's stock after acquiring an additional 60,762 sMay 8, 2025 | marketbeat.comClearPoint Neuro (CLPT) to Release Earnings on TuesdayClearPoint Neuro (NASDAQ:CLPT) will be releasing its Q1 2025 earnings after the market closes on Tuesday, May 13. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-13-clearpoint-neuro-inc-stock/)May 8, 2025 | marketbeat.com683 Capital Management LLC Invests $836,000 in ClearPoint Neuro, Inc. (NASDAQ:CLPT)683 Capital Management LLC acquired a new stake in shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 54,387 shares ofMay 4, 2025 | marketbeat.comMGO One Seven LLC Buys New Shares in ClearPoint Neuro, Inc. (NASDAQ:CLPT)MGO One Seven LLC purchased a new position in shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) in the fourth quarter, according to its most recent filing with the SEC. The firm purchased 17,460 shares of the company's stock, valued at approximately $269,000. MGO One Seven LLC owned 0.06May 2, 2025 | marketbeat.comClearPoint Neuro expands FDA application for MRI systemApril 29, 2025 | investing.comInvesco Ltd. Purchases Shares of 247,977 ClearPoint Neuro, Inc. (NASDAQ:CLPT)Invesco Ltd. acquired a new position in ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 247,977 shares of the company's stock, valued at approximately $3,814,000. Invesco Ltd. owned aboApril 29, 2025 | marketbeat.comClearPoint Neuro: Fundamentals Continue To StrengthenApril 29, 2025 | seekingalpha.comThe five-year returns have been incredible for ClearPoint Neuro (NASDAQ:CLPT) shareholders despite underlying losses increasingApril 27, 2025 | uk.finance.yahoo.comClearPoint Neuro price target raised to $28 from $20 at B. RileyApril 27, 2025 | markets.businessinsider.comClearPoint Neuro announces market release of Navigation Software Version 3.0April 25, 2025 | markets.businessinsider.comEAM Investors LLC Has $739,000 Holdings in ClearPoint Neuro, Inc. (NASDAQ:CLPT)EAM Investors LLC cut its holdings in shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) by 39.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 48,034 shares of the company's stock after selling 30,958 shares duApril 20, 2025 | marketbeat.comClearPoint Neuro (NASDAQ:CLPT) Stock Price Expected to Rise, Stifel Nicolaus Analyst SaysStifel Nicolaus lifted their target price on shares of ClearPoint Neuro from $19.00 to $25.00 and gave the company a "buy" rating in a report on Tuesday.April 2, 2025 | marketbeat.comHere's Why We're Not Too Worried About ClearPoint Neuro's (NASDAQ:CLPT) Cash Burn SituationMarch 30, 2025 | finance.yahoo.comVirtu Financial LLC Acquires Shares of 20,576 ClearPoint Neuro, Inc. (NASDAQ:CLPT)Virtu Financial LLC bought a new stake in ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 20,576 shares of the company's stock, valued at approximately $316,000. Virtu FinanciMarch 29, 2025 | marketbeat.comEssex Investment Management Co. LLC Has $6.29 Million Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT)Essex Investment Management Co. LLC reduced its stake in shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) by 11.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 408,822 shares of the company's stock after selling 55,031 sharMarch 10, 2025 | marketbeat.comClearPoint Neuro (CLPT) Receives a Buy from Stifel NicolausMarch 4, 2025 | markets.businessinsider.comClearPoint Neuro (CLPT) Projected to Post Quarterly Earnings on TuesdayClearPoint Neuro (NASDAQ:CLPT) will be releasing earnings after the market closes on Tuesday, March 11. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=666799)March 4, 2025 | marketbeat.comWhat is B. Riley's Forecast for CLPT FY2025 Earnings?ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) - Analysts at B. Riley raised their FY2025 EPS estimates for ClearPoint Neuro in a note issued to investors on Thursday, February 27th. B. Riley analyst K. Bauser now anticipates that the company will post earnings of ($0.58) per share for the yeMarch 3, 2025 | marketbeat.comClearPoint Neuro: Drug Delivery Prospects Continue To StrengthenFebruary 28, 2025 | seekingalpha.comClearPoint Neuro (NASDAQ:CLPT) Posts Earnings Results, Misses Expectations By $0.05 EPSClearPoint Neuro (NASDAQ:CLPT - Get Free Report) released its quarterly earnings results on Wednesday. The company reported ($0.20) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.15) by ($0.05). ClearPoint Neuro had a negative return on equity of 62.10% and a negative net margin of 59.64%.February 27, 2025 | marketbeat.comClearPoint Neuro, Inc. (NASDAQ:CLPT) Shares Sold by Taylor Frigon Capital Management LLCTaylor Frigon Capital Management LLC trimmed its holdings in ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) by 43.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 212,246 shares of the company's stock afFebruary 27, 2025 | marketbeat.comClearPoint Neuro reports Q4 revenue $7.8M, consensus $8.23MFebruary 26, 2025 | markets.businessinsider.comClearPoint Neuro, Inc. (CLPT) Q4 2024 Earnings Call TranscriptFebruary 26, 2025 | seekingalpha.comClearPoint Neuro, Inc.: ClearPoint Neuro Reports Fourth Quarter and Full Year 2024 ResultsFebruary 26, 2025 | finanznachrichten.deClearPoint Neuro Inc (CLPT) Q4 2024: Everything You Need To Know Ahead Of EarningsFebruary 25, 2025 | finance.yahoo.comLake Street Sticks to Its Buy Rating for ClearPoint Neuro (CLPT)February 24, 2025 | markets.businessinsider.comBradley Foster & Sargent Inc. CT Buys New Holdings in ClearPoint Neuro, Inc. (NASDAQ:CLPT)Bradley Foster & Sargent Inc. CT purchased a new position in shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 56,663 shares of the company's stock, valued at approximately $871,000. BradleyFebruary 23, 2025 | marketbeat.comClearPoint Neuro (CLPT) Projected to Post Earnings on WednesdayClearPoint Neuro (NASDAQ:CLPT) will be releasing earnings after the market closes on Wednesday, February 26, Financial Modeling Prep reports.February 21, 2025 | marketbeat.comWhile institutions own 33% of ClearPoint Neuro, Inc. (NASDAQ:CLPT), individual investors are its largest shareholders with 59% ownershipFebruary 20, 2025 | finance.yahoo.comClearPoint Neuro, Inc. (NASDAQ:CLPT) Sees Large Decline in Short InterestClearPoint Neuro, Inc. (NASDAQ:CLPT - Get Free Report) saw a significant decline in short interest during the month of January. As of January 31st, there was short interest totalling 653,400 shares, a decline of 22.1% from the January 15th total of 838,600 shares. Based on an average trading volume of 235,700 shares, the days-to-cover ratio is currently 2.8 days.February 16, 2025 | marketbeat.comClearPoint Neuro, Inc.: ClearPoint Neuro Announces EU MDR Certification for the SmartFlow CannulaFebruary 13, 2025 | finanznachrichten.deClearPoint Neuro, Inc. (NASDAQ:CLPT) Shares Sold by Legato Capital Management LLCLegato Capital Management LLC lowered its holdings in ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) by 23.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 122,057 shares of the company's stock aFebruary 12, 2025 | marketbeat.comClearPoint Neuro (NASDAQ:CLPT) Sets New 12-Month High - Time to Buy?ClearPoint Neuro (NASDAQ:CLPT) Reaches New 52-Week High - Here's What HappenedFebruary 6, 2025 | marketbeat.comClearPoint Neuro (NASDAQ:CLPT) Stock Price Up 8.5% - Still a Buy?ClearPoint Neuro (NASDAQ:CLPT) Trading Up 8.5% - Should You Buy?February 4, 2025 | marketbeat.comStifel maintains Clearpoint Neuro stock Buy rating, $17 targetJanuary 29, 2025 | msn.comClearPoint Neuro price target raised to $20 from $15 at B. RileyJanuary 29, 2025 | finance.yahoo.com Get ClearPoint Neuro News Delivered to You Automatically Sign up to receive the latest news and ratings for CLPT and its competitors with MarketBeat's FREE daily newsletter. Email Address CLPT Media Mentions By Week CLPT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CLPT News Sentiment▼0.300.65▲Average Medical News Sentiment CLPT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CLPT Articles This Week▼102▲CLPT Articles Average Week Get ClearPoint Neuro News Delivered to You Automatically Sign up to receive the latest news and ratings for CLPT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Liquidia News Today Cadre News Today Artivion News Today Kestra Medical Technologies News Today Pulse Biosciences News Today Paragon 28 News Today BioLife Solutions News Today Establishment Labs News Today MiMedx Group News Today InMode News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CLPT) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ClearPoint Neuro, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ClearPoint Neuro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CLPT Stock Free CLPT Stock Alerts